In this study, we employed chromatin immunoprecipitation sequencing (ChIP-seq)technology to study the potential targets of USP22 in human cervical cancer cells.Furthermore, we explored transcriptome profiling in response to USP22 silencing. This evidence concerns the gene USP22 and cervical carcinoma.